ZAPROSZENIE – Wykład profesora Josefa Jampilka, „Investigations of Derivatives of Hydroxyarylcarboxylic Acids as Multi-Target Agents”

Josef Jampilek completed his Ph.D. degree in Medicinal Chemistry at the Faculty of Pharmacy of the Charles University (Czechia) in 2004. In 2004-2011, he worked in expert and managerial posts in the R&D Division of the pharmaceutical company Zentiva (Czechia). Prof. Jampilek deepened his professional knowledge at the Medicinal Chemistry Institute of the Heidelberg University (Germany) and at multiple specialized courses. In 2017, he was designated as a Full Professor of Medicinal Chemistry. He works at the Faculty of Natural Sciences of the Comenius University in Bratislava (Slovakia) and the Faculty of Science of the Palacky University in Olomouc (Czechia). In addition, he is a visiting professor at several universities and an invited professor/expert at various higher educational institutions. He is an author/co-author of more than 30 patents/patent applications, more than 260 peer-reviewed scientific publications, 9 textbooks, more than 45 chapters in monographs, and many invited lectures at international conferences and workshops. He also received several awards for his scientific results, e.g., from Aventis, Elsevier, Willey, Sanofi and FDA. Prof. Jampilek is also an editor, guest editor and member of the editorial boards of several renowned international scientific journals. The research interests of Prof. Jampilek include drug design, medicinal chemistry, chemical biology as well as drug delivery nanosystems. He is also interested in ADME and solid-state pharmaceutical analysis.